RecruitingNCT06160310

Tuberous Sclerosis Complex and Lymphangioleiomyomatosis Pregnancy Registry (TSC-LAM Registry)

Tuberous Sclerosis Complex and Lymphangioleiomyomatosis Pregnancy Registry


Sponsor

David M. Ritter

Enrollment

300 participants

Start Date

Jul 1, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

This study is an observational registry designed to gather information about Tuberous Sclerosis Complex (TSC) and Lymphangioleiomyomatosis (LAM) in pregnant women and their child.


Eligibility

Sex: FEMALE

Plain Language Summary

Simplified for easier understanding

This registry is collecting information about pregnancies in women who have tuberous sclerosis complex (TSC) or lymphangioleiomyomatosis (LAM) — rare genetic conditions that can affect the lungs, kidneys, and other organs. The goal is to better understand how these conditions affect pregnancy and vice versa, and to guide future care. **You may be eligible if...** - You are pregnant - You have a clinical or genetic diagnosis of tuberous sclerosis complex (TSC) or lymphangioleiomyomatosis (LAM) - Or you carry a variant of uncertain significance in the TSC1 or TSC2 genes and are pregnant - Or your baby's father has TSC and you are pregnant **You may NOT be eligible if...** - You are not pregnant - You do not have TSC, LAM, or a relevant genetic variant - You do not meet any of the listed diagnostic criteria Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Cincinnati Children's Hospital Medical Center

Cincinnati, Ohio, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06160310


Related Trials